Sun et al. demonstrated that elevated expression of CENP-A, which maintains the structure, formation, number and function of centromeres, can be used as a prognostic and predictive cancer biomarker as its expression strongly correlates with a positive response to taxane-based regimens in breast cancer [41]. This evidence concerns the gene CENPA and breast carcinoma.